Reportedly among the recent job cuts at the FDA were workers overseeing the review of Musk’s brain chip-implant company, Neuralink.
Since the moment the Department of Government Efficiency (DOGE) was first proposed, Elon Musk’s critics have warned that the world’s richest man was at risk of making decisions that could be a conflict of interest, given his multiple business operations. With recent cuts at the Food and Drug Administration (FDA), those fears are increasing.
Published on February 18, 2025 23:20